Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

Earlier diagnosis, access to disease-modifying therapies (DMTs), and improved supportive care have favorably altered the disease course of multiple sclerosis (MS), leading to an improvement in long-term outcomes for people with MS (PwMS). This success has changed the medical characteristics of the p...

Full description

Bibliographic Details
Main Authors: Massimiliano Mirabella, Pietro Annovazzi, Wallace Brownlee, Jeffrey A. Cohen, Christoph Kleinschnitz, Christian Wolf
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Neurology
Subjects:
disease modifying treatment
glatiramer acetate
special populations
multiple sclerosis
comorbidities
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.844873/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.844873/full

Similar Items